Ccl5 | Mouse | (+)-catechin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Oxygen deficiency co-treated with Catechin] results in increased expression of CCL5 mRNA | CTD | PMID:35883890 |
Ccl5 | Mouse | (-)-alpha-phellandrene | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | alpha phellandrene results in increased expression of CCL5 mRNA | CTD | PMID:25075043 |
Ccl5 | Mouse | (-)-anisomycin | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Anisomycin results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | (-)-demecolcine | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Demecolcine results in increased expression of CCL5 mRNA | CTD | PMID:23649840 |
Ccl5 | Mouse | (4-oxo-3-\{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl\}-3,4-dihydrophthalazin-1-yl)acetic acid | multiple interactions | EXP | | 6480464 | zopolrestat inhibits the reaction [Antigens and Plant results in increased expression of CCL5 mRNA] | CTD | PMID:21334316 |
Ccl5 | Mouse | (R)-noradrenaline | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | Norepinephrine results in increased secretion of CCL5 protein | CTD | PMID:16782692 |
Ccl5 | Mouse | (R)-noradrenaline | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Prazosin inhibits the reaction [Norepinephrine results in increased secretion of CCL5 protein] | CTD | PMID:16782692 |
Ccl5 | Mouse | (S)-nicotine | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Nicotine results in increased expression of CCL5 mRNA | CTD | PMID:18247414 |
Ccl5 | Mouse | 1,4-benzoquinone | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | quinone results in increased expression of CCL5 protein | CTD | PMID:17572062 |
Ccl5 | Mouse | 1,4-phenylenediamine | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | 4-phenylenediamine results in increased expression of CCL5 mRNA | CTD | PMID:27585668 |
Ccl5 | Mouse | 1-Aminopyrene | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | 1-aminopyrene results in increased expression of CCL5 mRNA | CTD | PMID:19879285 |
Ccl5 | Mouse | 1-chloro-2,4-dinitrobenzene | multiple interactions | EXP | | 6480464 | diflorasone inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL5 protein] | CTD | PMID:15491423 |
Ccl5 | Mouse | 1-chloro-2,4-dinitrobenzene | decreases expression | EXP | | 6480464 | Dinitrochlorobenzene results in decreased expression of CCL5 mRNA | CTD | PMID:21404309 and PMID:28219650 |
Ccl5 | Mouse | 1-chloro-2,4-dinitrobenzene | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | Dinitrochlorobenzene results in increased secretion of CCL5 protein | CTD | PMID:20488241 |
Ccl5 | Mouse | 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of CCL5 protein | CTD | PMID:15491423 |
Ccl5 | Mouse | 1-fluoro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrofluorobenzene results in increased expression of CCL5 mRNA and Dinitrofluorobenzene results in increased expression of CCL5 protein | CTD | PMID:15719370 |
Ccl5 | Mouse | 1-naphthyl isothiocyanate | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate affects the expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | 1-naphthyl isothiocyanate | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of CCL5 mRNA | CTD | PMID:30723492 |
Ccl5 | Mouse | 1-naphthyl isothiocyanate | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CCL5 mRNA | CTD | PMID:25380136 |
Ccl5 | Mouse | 1-nitropyrene | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | 1-nitropyrene results in increased expression of CCL5 mRNA | CTD | PMID:19879285 |
Ccl5 | Mouse | 14-Deoxy-11,12-didehydroandrographolide | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | 14-deoxy-11 and 12-didehydroandrographolide analog inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | CTD | PMID:27089844 |
Ccl5 | Mouse | 15-deoxy-Delta(12,14)-prostaglandin J2 | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | 15-deoxy-delta(12 and 14)-prostaglandin J2 inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] | CTD | PMID:23688403 |
Ccl5 | Mouse | 17alpha-ethynylestradiol | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in decreased expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of CCL5 mRNA | CTD | PMID:15885639 |
Ccl5 | Mouse | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of CCL5 mRNA | CTD | PMID:12538720 |
Ccl5 | Mouse | 17beta-estradiol | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Estradiol co-treated with norethindrone acetate] results in decreased expression of CCL5 protein and [Progesterone co-treated with Estradiol] results in decreased expression of CCL5 mRNA | CTD | PMID:16842799 and PMID:17404688 |
Ccl5 | Mouse | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CCL5 mRNA | CTD | PMID:19484750 and PMID:39298647 |
Ccl5 | Mouse | 17beta-estradiol | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL5 mRNA more ... | CTD | PMID:21277368 and PMID:32741896 |
Ccl5 | Mouse | 17beta-estradiol | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Estradiol results in increased expression of CCL5 mRNA | CTD | PMID:21185374 |
Ccl5 | Mouse | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL5 mRNA | CTD | PMID:32741896 |
Ccl5 | Mouse | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:30294300 |
Ccl5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [[AHR protein binds to CCL5 enhancer] which results in increased expression of CCL5 mRNA] more ... | CTD | PMID:12200463 and PMID:14761676 |
Ccl5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CCL5 mRNA | CTD | PMID:34747641 |
Ccl5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL5 mRNA | CTD | PMID:26377647 |
Ccl5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL5 mRNA | CTD | PMID:22808131 |
Ccl5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCL5 mRNA | CTD | PMID:20059583 more ... |
Ccl5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CCL5 mRNA | CTD | PMID:21570461 and PMID:28213091 |
Ccl5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCL5 mRNA | CTD | PMID:18684927 more ... |
Ccl5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with TNF protein] affects the expression of CCL5 mRNA more ... | CTD | PMID:20819909 and PMID:21979172 |
Ccl5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL5 mRNA | CTD | PMID:12200463 |
Ccl5 | Mouse | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:38648751 |
Ccl5 | Mouse | 2,6-di-tert-butyl-4-methylphenol | decreases expression | EXP | | 6480464 | Butylated Hydroxytoluene results in decreased expression of CCL5 mRNA | CTD | PMID:19925653 |
Ccl5 | Mouse | 2-amino-2-deoxy-D-galactopyranose | multiple interactions | EXP | | 6480464 | [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CCL5 mRNA more ... | CTD | PMID:21146893 |
Ccl5 | Mouse | 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL5 protein] | CTD | PMID:18080321 |
Ccl5 | Mouse | 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CCL5 mRNA] | CTD | PMID:17109745 |
Ccl5 | Mouse | 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] | CTD | PMID:23688403 |
Ccl5 | Mouse | 2-naphthylamine | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | 2-Naphthylamine results in increased expression of CCL5 mRNA | CTD | PMID:18247414 |
Ccl5 | Mouse | 2-tert-butylhydroquinone | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone results in increased secretion of CCL5 protein | CTD | PMID:30806763 |
Ccl5 | Mouse | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:34256052 |
Ccl5 | Mouse | 3,3',5-triiodo-L-thyronine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | 4-OH-2' more ... | CTD | PMID:14761676 |
Ccl5 | Mouse | 3,3',5-triiodo-L-thyronine | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Triiodothyronine results in increased expression of CCL5 mRNA | CTD | PMID:14761676 |
Ccl5 | Mouse | 3,7-dihydropurine-6-thione | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Mercaptopurine results in decreased expression of CCL5 mRNA | CTD | PMID:23358152 |
Ccl5 | Mouse | 3-chloropropane-1,2-diol | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in decreased expression of CCL5 mRNA | CTD | PMID:28522335 |
Ccl5 | Mouse | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA | CTD | PMID:23503329 |
Ccl5 | Mouse | 3-methylcholanthrene | decreases expression | EXP | | 6480464 | Methylcholanthrene results in decreased expression of CCL5 mRNA | CTD | PMID:20713471 |
Ccl5 | Mouse | 3-phenylprop-2-enal | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | cinnamaldehyde results in increased secretion of CCL5 protein | CTD | PMID:20488241 |
Ccl5 | Mouse | 3-phenylprop-2-enal | decreases expression | EXP | | 6480464 | cinnamaldehyde results in decreased expression of CCL5 mRNA | CTD | PMID:28219650 |
Ccl5 | Mouse | 3H-1,2-dithiole-3-thione | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of CCL5 mRNA | CTD | PMID:19162173 |
Ccl5 | Mouse | 4,4'-diaminodiphenylmethane | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of CCL5 mRNA | CTD | PMID:25380136 |
Ccl5 | Mouse | 4,4'-sulfonyldiphenol | decreases expression | EXP | | 6480464 | bisphenol S results in decreased expression of CCL5 mRNA | CTD | PMID:39298647 |
Ccl5 | Mouse | 4-(ethoxymethylene)-2-phenyloxazol-5-one | decreases expression | EXP | | 6480464 | Oxazolone results in decreased expression of CCL5 mRNA | CTD | PMID:21404309 |
Ccl5 | Mouse | 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CCL5 mRNA | CTD | PMID:19191707 |
Ccl5 | Mouse | 4-hydroxynon-2-enal | multiple interactions | EXP | | 6480464 | 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] and 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein] | CTD | PMID:19627980 |
Ccl5 | Mouse | 4-nitroquinoline N-oxide | increases expression | EXP | | 6480464 | 4-Nitroquinoline-1-oxide results in increased expression of CCL5 mRNA | CTD | PMID:22561872 |
Ccl5 | Mouse | 4-nitroquinoline N-oxide | decreases expression | EXP | | 6480464 | 4-Nitroquinoline-1-oxide results in decreased expression of CCL5 mRNA | CTD | PMID:22561872 |
Ccl5 | Mouse | 7,12-dimethyltetraphene | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | 9 more ... | CTD | PMID:12200463 |
Ccl5 | Mouse | 7,12-dimethyltetraphene | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | 9 more ... | CTD | PMID:19480007 |
Ccl5 | Mouse | 7-ketocholesterol | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CCL5 protein] | CTD | PMID:24895526 |
Ccl5 | Mouse | 7-ketocholesterol | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | 7-ketocholesterol results in increased expression of CCL5 protein | CTD | PMID:24895526 |
Ccl5 | Mouse | 8-Br-cAMP | multiple interactions | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] and 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | CTD | PMID:10495789 |
Ccl5 | Mouse | 8-chloro-2'-deoxyguanosine | decreases expression | EXP | | 6480464 | 8-chloro-2'-deoxyguanosine results in decreased expression of CCL5 mRNA | CTD | PMID:31066272 |
Ccl5 | Mouse | 9,10-anthraquinone | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | 9 and 10-anthraquinone results in increased expression of CCL5 mRNA | CTD | PMID:23333790 |
Ccl5 | Mouse | 9-hydroxycanthin-6-one | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | 9-hydroxycanthin-6-one results in decreased expression of CCL5 mRNA | CTD | PMID:29225138 |
Ccl5 | Mouse | acetamide | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of CCL5 mRNA | CTD | PMID:31881176 |
Ccl5 | Mouse | acrolein | multiple interactions | EXP | | 6480464 | CD8A protein promotes the reaction [Acrolein results in increased expression of CCL5 mRNA] | CTD | PMID:17950725 |
Ccl5 | Mouse | acrolein | increases expression | EXP | | 6480464 | Acrolein results in increased expression of CCL5 mRNA | CTD | PMID:17950725 |
Ccl5 | Mouse | adenine | increases expression | EXP | | 6480464 | Adenine results in increased expression of CCL5 mRNA | CTD | PMID:34619300 |
Ccl5 | Mouse | albuterol | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Beclomethasone co-treated with Albuterol] results in decreased secretion of CCL5 protein | CTD | PMID:15679717 |
Ccl5 | Mouse | aldehydo-D-glucosamine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL5 protein] | CTD | PMID:18080321 |
Ccl5 | Mouse | aldehydo-D-glucosamine | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CCL5 mRNA] | CTD | PMID:17109745 |
Ccl5 | Mouse | aldehydo-D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL5 mRNA | CTD | PMID:17178593 |
Ccl5 | Mouse | aldehydo-D-glucose | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Glucose results in increased expression of CCL5 mRNA | CTD | PMID:31655124 |
Ccl5 | Mouse | aldehydo-D-glucose | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Glucose results in decreased expression of CCL5 mRNA | CTD | PMID:32942007 |
Ccl5 | Mouse | aldehydo-D-glucose | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA | CTD | PMID:32613381 |
Ccl5 | Mouse | alexidine | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | alexidine results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | all-trans-retinoic acid | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CCL5 protein | CTD | PMID:17118196 |
Ccl5 | Mouse | all-trans-retinoic acid | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of CCL5 mRNA | CTD | PMID:15498508 |
Ccl5 | Mouse | alpha-phellandrene | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | alpha phellandrene results in increased expression of CCL5 mRNA | CTD | PMID:25075043 |
Ccl5 | Mouse | alpha-Zearalanol | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Zeranol results in increased expression of CCL5 mRNA | CTD | PMID:35163327 |
Ccl5 | Mouse | aluminium hydroxide | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | Aluminum Hydroxide results in increased secretion of CCL5 protein | CTD | PMID:18390722 |
Ccl5 | Mouse | ammonium chloride | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of CCL5 mRNA | CTD | PMID:16483693 |
Ccl5 | Mouse | amorolfine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] | CTD | PMID:23688403 |
Ccl5 | Mouse | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | EXP | | 6480464 | pyrazolanthrone inhibits the reaction [Cyclosporine results in increased expression of CCL5 mRNA] and pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA] | CTD | PMID:23958496 |
Ccl5 | Mouse | antimycin A | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Antimycin A results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | antirheumatic drug | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of CCL5 mRNA | CTD | PMID:24449571 |
Ccl5 | Mouse | apocynin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | acetovanillone inhibits the reaction [TNF protein results in increased expression of CCL5 protein] | CTD | PMID:22414048 |
Ccl5 | Mouse | apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | CTD | PMID:10495789 |
Ccl5 | Mouse | arecoline | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | Arecoline results in increased secretion of CCL5 protein | CTD | PMID:21297082 |
Ccl5 | Mouse | aripiprazole | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Aripiprazole co-treated with Ozone] results in increased expression of CCL5 mRNA | CTD | PMID:31476115 |
Ccl5 | Mouse | aristolochic acid A | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CCL5 mRNA | CTD | PMID:23912714 |
Ccl5 | Mouse | Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CCL5 mRNA | CTD | PMID:23650126 |
Ccl5 | Mouse | arsane | affects methylation | ISO | CCL5 (Homo sapiens) | 6480464 | Arsenic affects the methylation of CCL5 gene | CTD | PMID:25304211 |
Ccl5 | Mouse | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of CCL5 protein and Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of CCL5 protein] | CTD | PMID:35351628 and PMID:35777461 |
Ccl5 | Mouse | arsenic atom | affects methylation | ISO | CCL5 (Homo sapiens) | 6480464 | Arsenic affects the methylation of CCL5 gene | CTD | PMID:25304211 |
Ccl5 | Mouse | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of CCL5 protein and Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of CCL5 protein] | CTD | PMID:35351628 and PMID:35777461 |
Ccl5 | Mouse | arsenite(3-) | affects expression | ISO | CCL5 (Homo sapiens) | 6480464 | arsenite affects the expression of CCL5 mRNA | CTD | PMID:22959463 |
Ccl5 | Mouse | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of CCL5 protein | CTD | PMID:37166470 |
Ccl5 | Mouse | asbestos | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Asbestos results in increased expression of CCL5 protein | CTD | PMID:25162674 |
Ccl5 | Mouse | atropine | multiple interactions | EXP | | 6480464 | [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 mRNA] and [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 protein] | CTD | PMID:22245128 |
Ccl5 | Mouse | Bardoxolone methyl | multiple interactions | EXP | | 6480464 | bardoxolone methyl inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of CCL5 protein] | CTD | PMID:26918785 |
Ccl5 | Mouse | beclomethasone | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Beclomethasone results in decreased expression of CCL5 mRNA and Beclomethasone results in decreased expression of CCL5 protein | CTD | PMID:8534483 |
Ccl5 | Mouse | beclomethasone | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Beclomethasone co-treated with Albuterol] results in decreased secretion of CCL5 protein more ... | CTD | PMID:10903220 more ... |
Ccl5 | Mouse | benazepril | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | benazepril inhibits the reaction [Ethylene Glycol results in increased expression of CCL5 protein] | CTD | PMID:16284884 |
Ccl5 | Mouse | benzalkonium chloride | increases expression | EXP | | 6480464 | Benzalkonium Compounds results in increased expression of CCL5 protein | CTD | PMID:30517752 |
Ccl5 | Mouse | benzene | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Benzene results in increased expression of CCL5 mRNA and Benzene results in increased expression of CCL5 protein | CTD | PMID:11306435 and PMID:33064461 |
Ccl5 | Mouse | benzene-1,2,4-triol | affects expression | ISO | CCL5 (Homo sapiens) | 6480464 | hydroxyhydroquinone affects the expression of CCL5 protein | CTD | PMID:17572062 |
Ccl5 | Mouse | benzethonium chloride | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Benzethonium results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | benzo[a]pyrene | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CCL5 mRNA and Benzo(a)pyrene results in increased expression of CCL5 protein | CTD | PMID:11306435 and PMID:18247414 |
Ccl5 | Mouse | benzo[a]pyrene | affects methylation | ISO | CCL5 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CCL5 promoter | CTD | PMID:27901495 |
Ccl5 | Mouse | benzo[a]pyrene | increases methylation | ISO | CCL5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of CCL5 3' UTR | CTD | PMID:27901495 |
Ccl5 | Mouse | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL5 mRNA | CTD | PMID:27858113 |
Ccl5 | Mouse | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CCL5 mRNA | CTD | PMID:20713471 more ... |
Ccl5 | Mouse | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CCL5 mRNA | CTD | PMID:22228805 |
Ccl5 | Mouse | benzo[a]pyrene | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Benzo(a)pyrene results in decreased expression of CCL5 mRNA | CTD | PMID:21839799 |
Ccl5 | Mouse | benzo[a]pyrene | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein results in increased expression of CCL5 protein] | CTD | PMID:12200463 |
Ccl5 | Mouse | benzo[b]fluoranthene | decreases expression | EXP | | 6480464 | benzo(b)fluoranthene results in decreased expression of CCL5 mRNA | CTD | PMID:26377693 |
Ccl5 | Mouse | benzo[b]fluoranthene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL5 mRNA | CTD | PMID:27858113 |
Ccl5 | Mouse | Benzo[k]fluoranthene | decreases expression | EXP | | 6480464 | benzo(k)fluoranthene results in decreased expression of CCL5 mRNA | CTD | PMID:26377693 |
Ccl5 | Mouse | beryllium sulfate | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | beryllium sulfate results in increased expression of CCL5 mRNA | CTD | PMID:16314022 |
Ccl5 | Mouse | beta-D-glucosamine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL5 protein] | CTD | PMID:18080321 |
Ccl5 | Mouse | beta-D-glucosamine | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CCL5 mRNA] | CTD | PMID:17109745 |
Ccl5 | Mouse | beta-Funaltrexamine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | beta-funaltrexamine inhibits the reaction [Morphine results in decreased expression of CCL5 protein] | CTD | PMID:11106302 |
Ccl5 | Mouse | beta-naphthoflavone | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in decreased expression of CCL5 mRNA | CTD | PMID:32858204 |
Ccl5 | Mouse | bezafibrate | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Bezafibrate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of CCL5 mRNA] more ... | CTD | PMID:12126966 and PMID:12586603 |
Ccl5 | Mouse | bis(2-chloroethyl) sulfide | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Mustard Gas results in increased expression of CCL5 protein | CTD | PMID:17620002 |
Ccl5 | Mouse | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL5 mRNA more ... | CTD | PMID:34303773 more ... |
Ccl5 | Mouse | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of CCL5 mRNA | CTD | PMID:36583613 |
Ccl5 | Mouse | bisphenol A | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CCL5 mRNA | CTD | PMID:24988533 |
Ccl5 | Mouse | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CCL5 mRNA | CTD | PMID:35341816 |
Ccl5 | Mouse | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CCL5 mRNA | CTD | PMID:34281243 |
Ccl5 | Mouse | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A affects the susceptibility to Ovalbumin] which results in increased expression of and results in increased secretion of CCL5 protein | CTD | PMID:29737898 |
Ccl5 | Mouse | bisphenol A | increases methylation | ISO | Ccl5 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of CCL5 gene | CTD | PMID:28505145 |
Ccl5 | Mouse | bisphenol A | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of CCL5 mRNA | CTD | PMID:25181051 |
Ccl5 | Mouse | bleomycin A2 | increases expression | EXP | | 6480464 | Bleomycin results in increased expression of CCL5 mRNA | CTD | PMID:32828905 |
Ccl5 | Mouse | bleomycin A2 | multiple interactions | EXP | | 6480464 | SLCO2A1 gene mutant form promotes the reaction [Bleomycin results in increased expression of CCL5 mRNA] | CTD | PMID:32828905 |
Ccl5 | Mouse | Brevianamide A | increases expression | EXP | | 6480464 | brevianamide A results in increased expression of CCL5 mRNA | CTD | PMID:19818335 |
Ccl5 | Mouse | budesonide | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Budesonide inhibits the reaction [TNF protein results in increased secretion of CCL5 mRNA] and Budesonide inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] | CTD | PMID:10903220 and PMID:14643170 |
Ccl5 | Mouse | butanal | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of CCL5 mRNA | CTD | PMID:26079696 |
Ccl5 | Mouse | butenafine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | butenafine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] | CTD | PMID:23688403 |
Ccl5 | Mouse | Butylbenzyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL5 mRNA | CTD | PMID:37021957 |
Ccl5 | Mouse | cadmium atom | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of CCL5 mRNA | CTD | PMID:31904401 |
Ccl5 | Mouse | cadmium atom | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCL5 mRNA | CTD | PMID:35301059 |
Ccl5 | Mouse | cadmium dichloride | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased secretion of CCL5 protein | CTD | PMID:26138014 |
Ccl5 | Mouse | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of CCL5 mRNA | CTD | PMID:31904401 |
Ccl5 | Mouse | cadmium dichloride | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of CCL5 mRNA | CTD | PMID:38382870 |
Ccl5 | Mouse | cadmium dichloride | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCL5 mRNA and Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of CCL5 protein] | CTD | PMID:26138014 and PMID:35301059 |
Ccl5 | Mouse | Calcimycin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species] and IL5 protein promotes the reaction [CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]] | CTD | PMID:12797483 |
Ccl5 | Mouse | Calcimycin | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4 more ... | CTD | PMID:18083043 |
Ccl5 | Mouse | calcium atom | increases uptake | ISO | CCL5 (Homo sapiens) | 6480464 | CCL5 protein results in increased uptake of Calcium | CTD | PMID:10984371 |
Ccl5 | Mouse | calcium(0) | increases uptake | ISO | CCL5 (Homo sapiens) | 6480464 | CCL5 protein results in increased uptake of Calcium | CTD | PMID:10984371 |
Ccl5 | Mouse | camptothecin | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Camptothecin results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | cannabidiol | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Cannabidiol inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | CTD | PMID:31250491 |
Ccl5 | Mouse | carbon nanotube | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | Nanotubes and Carbon results in increased secretion of CCL5 protein | CTD | PMID:29348435 |
Ccl5 | Mouse | carbon nanotube | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | 1-palmitoyl-2-arachidonyl-3-phosphorylcholine metabolite inhibits the reaction [Nanotubes more ... | CTD | PMID:29348435 |
Ccl5 | Mouse | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 |
Ccl5 | Mouse | carbon nanotube | affects expression | EXP | | 6480464 | Nanotubes and Carbon affects the expression of CCL5 mRNA | CTD | PMID:23845593 |
Ccl5 | Mouse | carrageenan | increases expression | EXP | | 6480464 | Carrageenan results in increased expression of CCL5 protein | CTD | PMID:12444156 |
Ccl5 | Mouse | carrageenan | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] and Quercetin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] | CTD | PMID:14654164 |
Ccl5 | Mouse | catechol | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | catechol results in increased expression of CCL5 protein | CTD | PMID:17572062 |
Ccl5 | Mouse | celecoxib | decreases expression | EXP | | 6480464 | Celecoxib results in decreased expression of CCL5 mRNA | CTD | PMID:12902868 |
Ccl5 | Mouse | cephaeline | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | cephaelin results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | cerium trichloride | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | cerous chloride results in increased expression of CCL5 mRNA | CTD | PMID:28954213 |
Ccl5 | Mouse | cerium trichloride | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [cerous chloride co-treated with lanthanum chloride] results in increased expression of CCL5 mRNA | CTD | PMID:28954213 |
Ccl5 | Mouse | chenodeoxycholic acid | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Bezafibrate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of CCL5 mRNA] more ... | CTD | PMID:12126966 |
Ccl5 | Mouse | chenodeoxycholic acid | increases expression | EXP | | 6480464 | Chenodeoxycholic Acid results in increased expression of CCL5 mRNA | CTD | PMID:21224055 |
Ccl5 | Mouse | chenodeoxycholic acid | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Chenodeoxycholic Acid results in increased expression of CCL5 mRNA and Chenodeoxycholic Acid results in increased expression of CCL5 protein | CTD | PMID:12126966 |
Ccl5 | Mouse | chlorohydrocarbon | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [Hydrocarbons more ... | CTD | PMID:30744511 |
Ccl5 | Mouse | chloroprene | decreases expression | EXP | | 6480464 | Chloroprene results in decreased expression of CCL5 mRNA | CTD | PMID:23125180 |
Ccl5 | Mouse | chloroquine | multiple interactions | EXP | | 6480464 | Chloroquine inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased secretion of CCL5 protein] | CTD | PMID:22341560 |
Ccl5 | Mouse | choline | multiple interactions | EXP | | 6480464 | [PANX1 gene mutant form affects the susceptibility to [Dietary Fats co-treated with Choline deficiency]] which results in decreased expression of CCL5 protein | CTD | PMID:29246445 |
Ccl5 | Mouse | chromium(6+) | affects expression | EXP | | 6480464 | chromium hexavalent ion affects the expression of CCL5 mRNA | CTD | PMID:28472532 |
Ccl5 | Mouse | chrysene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL5 mRNA | CTD | PMID:27858113 |
Ccl5 | Mouse | ciglitazone | multiple interactions | EXP | | 6480464 | ciglitazone inhibits the reaction [Thioglycolates results in increased secretion of CCL5 protein] | CTD | PMID:12624547 |
Ccl5 | Mouse | cisplatin | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Cisplatin affects the expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of CCL5 mRNA and Cisplatin results in increased expression of CCL5 protein | CTD | PMID:15814532 more ... |
Ccl5 | Mouse | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with TNF protein] results in increased expression of CCL5 mRNA more ... | CTD | PMID:15814532 more ... |
Ccl5 | Mouse | clopidogrel | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | clopidogrel results in increased expression of CCL5 mRNA | CTD | PMID:16856976 |
Ccl5 | Mouse | cobalt atom | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA | CTD | PMID:23503329 |
Ccl5 | Mouse | codeine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Codeine affects the secretion of and affects the expression of CCL5 protein | CTD | PMID:17441793 |
Ccl5 | Mouse | colforsin daropate hydrochloride | multiple interactions | EXP | | 6480464 | Colforsin inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] and Colforsin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | CTD | PMID:10495789 |
Ccl5 | Mouse | copper atom | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Copper co-treated with Hydrogen Peroxide] promotes the reaction [CCL5 protein binds to CCL5 protein] more ... | CTD | PMID:21963154 and PMID:24690739 |
Ccl5 | Mouse | copper atom | increases secretion | EXP | | 6480464 | Copper results in increased secretion of CCL5 protein | CTD | PMID:19635393 |
Ccl5 | Mouse | copper(0) | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Copper co-treated with Hydrogen Peroxide] promotes the reaction [CCL5 protein binds to CCL5 protein] more ... | CTD | PMID:21963154 and PMID:24690739 |
Ccl5 | Mouse | copper(0) | increases secretion | EXP | | 6480464 | Copper results in increased secretion of CCL5 protein | CTD | PMID:19635393 |
Ccl5 | Mouse | cordycepin | decreases expression | EXP | | 6480464 | cordycepin results in decreased expression of CCL5 mRNA | CTD | PMID:20107539 |
Ccl5 | Mouse | crocidolite asbestos | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in decreased expression of CCL5 mRNA | CTD | PMID:29523930 |
Ccl5 | Mouse | crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos more ... | CTD | PMID:29507420 |
Ccl5 | Mouse | cycloheximide | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Cycloheximide results in increased expression of CCL5 mRNA | CTD | PMID:21146893 |
Ccl5 | Mouse | cycloheximide | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Cycloheximide inhibits the reaction [TNF protein results in increased expression of CCL5 protein] more ... | CTD | PMID:21146893 and PMID:22121136 |
Ccl5 | Mouse | cyclosporin A | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Cyclosporine affects the expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | cyclosporin A | multiple interactions | EXP | | 6480464 | 7-oxozeanol inhibits the reaction [Cyclosporine results in increased expression of CCL5 mRNA] more ... | CTD | PMID:23958496 and PMID:27585667 |
Ccl5 | Mouse | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CCL5 mRNA and Cyclosporine results in increased expression of CCL5 protein | CTD | PMID:19770486 more ... |
Ccl5 | Mouse | cyfluthrin | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | cyfluthrin results in increased expression of CCL5 mRNA | CTD | PMID:31330490 |
Ccl5 | Mouse | cyfluthrin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Melatonin inhibits the reaction [cyfluthrin results in increased expression of CCL5 mRNA] | CTD | PMID:31330490 |
Ccl5 | Mouse | cytidine | multiple interactions | EXP | | 6480464 | [Chlorine binds to Cytidine] which results in decreased expression of CCL5 mRNA | CTD | PMID:31066272 |
Ccl5 | Mouse | D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL5 mRNA | CTD | PMID:17178593 |
Ccl5 | Mouse | D-glucose | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Glucose results in decreased expression of CCL5 mRNA | CTD | PMID:32942007 |
Ccl5 | Mouse | D-glucose | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Glucose results in increased expression of CCL5 mRNA | CTD | PMID:31655124 |
Ccl5 | Mouse | D-glucose | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA | CTD | PMID:32613381 |
Ccl5 | Mouse | D-penicillamine | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Penicillamine results in increased expression of CCL5 mRNA | CTD | PMID:19575532 |
Ccl5 | Mouse | dantrolene | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Dantrolene affects the expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | decabromodiphenyl ether | affects expression | EXP | | 6480464 | decabromobiphenyl ether affects the expression of CCL5 protein | CTD | PMID:21791381 |
Ccl5 | Mouse | deguelin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | deguelin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | CTD | PMID:28529457 |
Ccl5 | Mouse | deoxycholic acid | increases expression | EXP | | 6480464 | Deoxycholic Acid results in increased expression of CCL5 mRNA | CTD | PMID:21224055 |
Ccl5 | Mouse | deoxynivalenol | increases expression | EXP | | 6480464 | deoxynivalenol results in increased expression of CCL5 mRNA | CTD | PMID:22968694 and PMID:35925383 |
Ccl5 | Mouse | deoxynivalenol | multiple interactions | EXP | | 6480464 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of CCL5 mRNA] | CTD | PMID:35925383 |
Ccl5 | Mouse | deoxynivalenol | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | deoxynivalenol results in increased expression of CCL5 mRNA | CTD | PMID:27757495 |
Ccl5 | Mouse | dequalinium | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Dequalinium results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | desipramine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Desipramine inhibits the reaction [TNF protein results in increased expression of CCL5 protein] | CTD | PMID:17477857 |
Ccl5 | Mouse | dexamethasone | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Dexamethasone inhibits the reaction [[Toluene 2 more ... | CTD | PMID:16908450 and PMID:27568862 |
Ccl5 | Mouse | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CCL5 mRNA | CTD | PMID:21041162 |
Ccl5 | Mouse | dexamethasone | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Dexamethasone inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4] and Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] | CTD | PMID:18083043 |
Ccl5 | Mouse | dexamethasone | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA more ... | CTD | PMID:10495789 more ... |
Ccl5 | Mouse | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of CCL5 protein | CTD | PMID:37166470 |
Ccl5 | Mouse | Dibutyl phosphate | affects expression | ISO | CCL5 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of CCL5 mRNA | CTD | PMID:37042841 |
Ccl5 | Mouse | dibutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL5 mRNA | CTD | PMID:37021957 |
Ccl5 | Mouse | dibutylstannane | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [di-n-butyltin co-treated with LHB protein] results in increased secretion of CCL5 protein | CTD | PMID:38630605 |
Ccl5 | Mouse | dichlorine | increases expression | EXP | | 6480464 | Chlorine results in increased expression of CCL5 protein | CTD | PMID:23146759 |
Ccl5 | Mouse | dichlorine | multiple interactions | EXP | | 6480464 | [Chlorine binds to Cytidine] which results in decreased expression of CCL5 mRNA | CTD | PMID:31066272 |
Ccl5 | Mouse | dichloromethane | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Methylene Chloride results in decreased expression of CCL5 mRNA | CTD | PMID:20955722 |
Ccl5 | Mouse | Didecyldimethylammonium | increases expression | EXP | | 6480464 | didecyldimethylammonium results in increased expression of CCL5 protein | CTD | PMID:19762220 |
Ccl5 | Mouse | diethyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL5 mRNA | CTD | PMID:37021957 |
Ccl5 | Mouse | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of CCL5 mRNA | CTD | PMID:21041162 |
Ccl5 | Mouse | diethylstilbestrol | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Diethylstilbestrol results in increased expression of CCL5 mRNA | CTD | PMID:37077353 |
Ccl5 | Mouse | diflorasone | multiple interactions | EXP | | 6480464 | diflorasone inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL5 protein] more ... | CTD | PMID:15491423 |
Ccl5 | Mouse | digitoxigenin | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Digitoxigenin results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | digoxin | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Digoxin results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | diisobutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL5 mRNA | CTD | PMID:37021957 |
Ccl5 | Mouse | diisononyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL5 mRNA | CTD | PMID:37021957 |
Ccl5 | Mouse | dimethyl sulfoxide | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Dimethyl Sulfoxide inhibits the reaction [[Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased secretion of CCL5 protein] | CTD | PMID:21878375 |
Ccl5 | Mouse | dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Benzethonium results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | dinitrogen | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of CCL5 protein | CTD | PMID:30711708 |
Ccl5 | Mouse | dioxygen | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Oxygen results in increased expression of CCL5 mRNA | CTD | PMID:27103661 |
Ccl5 | Mouse | dioxygen | multiple interactions | EXP | | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL5 mRNA | CTD | PMID:30529165 |
Ccl5 | Mouse | dioxygen | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Oxygen deficiency co-treated with Catechin] results in increased expression of CCL5 mRNA and Oxygen affects the reaction [AHR protein results in increased expression of CCL5 mRNA] | CTD | PMID:27103661 and PMID:35883890 |
Ccl5 | Mouse | disulfiram | multiple interactions | EXP | | 6480464 | Disulfiram inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide] more ... | CTD | PMID:19016906 |
Ccl5 | Mouse | disulfiram | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in increased expression of CCL5 mRNA | CTD | PMID:24690739 |
Ccl5 | Mouse | diuron | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Diuron results in decreased expression of CCL5 mRNA | CTD | PMID:35967413 |
Ccl5 | Mouse | doxorubicin | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CCL5 mRNA | CTD | PMID:29803840 |
Ccl5 | Mouse | emetine | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Emetine results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | endosulfan | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Endosulfan results in increased expression of CCL5 mRNA | CTD | PMID:28108160 |
Ccl5 | Mouse | enilconazole | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | enilconazole results in increased expression of CCL5 mRNA | CTD | PMID:32201337 |
Ccl5 | Mouse | Erionite | increases expression | EXP | | 6480464 | erionite results in increased expression of CCL5 protein | CTD | PMID:29279043 |
Ccl5 | Mouse | ethambutol | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Ethambutol affects the expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | ethanol | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | Ethanol results in increased secretion of CCL5 protein | CTD | PMID:28763032 |
Ccl5 | Mouse | ethionamide | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Ethionamide affects the expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | ethyl acetate | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | ethyl acetate results in increased expression of CCL5 protein | CTD | PMID:11306435 |
Ccl5 | Mouse | Ethyl icosapentate | multiple interactions | EXP | | 6480464 | [eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of CCL5 mRNA | CTD | PMID:23665937 |
Ccl5 | Mouse | ethylbenzene | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | ethylbenzene results in decreased expression of CCL5 mRNA | CTD | PMID:20955722 |
Ccl5 | Mouse | ethylene glycol | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Ethylene Glycol results in increased expression of CCL5 protein | CTD | PMID:16284884 |
Ccl5 | Mouse | ethylene glycol | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | benazepril inhibits the reaction [Ethylene Glycol results in increased expression of CCL5 protein] more ... | CTD | PMID:16284884 |
Ccl5 | Mouse | ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased secretion of CCL5 protein] | CTD | PMID:21245013 |
Ccl5 | Mouse | fenofibrate | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Fenofibrate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of CCL5 mRNA] more ... | CTD | PMID:12126966 and PMID:12586603 |
Ccl5 | Mouse | ferric oxide | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | ferric oxide analog results in increased expression of CCL5 mRNA | CTD | PMID:38615722 |
Ccl5 | Mouse | Fexofenadine hydrochloride | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | fexofenadine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] more ... | CTD | PMID:15460210 |
Ccl5 | Mouse | flavonoids | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Flavonoids results in decreased expression of CCL5 mRNA | CTD | PMID:18035473 |
Ccl5 | Mouse | flunisolide | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | flunisolide inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] | CTD | PMID:10903220 |
Ccl5 | Mouse | fluoxetine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Fluoxetine inhibits the reaction [TNF protein results in increased expression of CCL5 protein] | CTD | PMID:17477857 |
Ccl5 | Mouse | flutamide | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Flutamide affects the expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | fluticasone | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Fluticasone inhibits the reaction [TNF protein results in increased expression of CCL5 protein] more ... | CTD | PMID:10903220 more ... |
Ccl5 | Mouse | folic acid | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Folic Acid results in increased expression of CCL5 mRNA | CTD | PMID:28752528 |
Ccl5 | Mouse | folic acid | increases expression | EXP | | 6480464 | Folic Acid results in increased expression of CCL5 mRNA | CTD | PMID:25629700 and PMID:34619300 |
Ccl5 | Mouse | formaldehyde | multiple interactions | EXP | | 6480464 | Formaldehyde promotes the reaction [Antigens and Dermatophagoides results in increased expression of CCL5 protein] | CTD | PMID:12435080 |
Ccl5 | Mouse | formaldehyde | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of CCL5 mRNA | CTD | PMID:28937961 |
Ccl5 | Mouse | formaldehyde | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of CCL5 mRNA | CTD | PMID:23649840 |
Ccl5 | Mouse | formoterol fumarate | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Beclomethasone co-treated with Formoterol Fumarate] results in decreased secretion of CCL5 protein | CTD | PMID:15679717 |
Ccl5 | Mouse | fragrance | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Perfume results in increased expression of CCL5 mRNA | CTD | PMID:24768652 |
Ccl5 | Mouse | fucoidan | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | fucoidan results in decreased expression of CCL5 protein | CTD | PMID:16201850 |
Ccl5 | Mouse | fulvestrant | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | fulvestrant results in increased expression of CCL5 mRNA | CTD | PMID:12154049 |
Ccl5 | Mouse | fumonisin B1 | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | fumonisin B1 results in increased expression of CCL5 mRNA | CTD | PMID:27757495 |
Ccl5 | Mouse | gemfibrozil | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Gemfibrozil results in decreased expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | gentamycin | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of CCL5 mRNA | CTD | PMID:22061828 and PMID:33387578 |
Ccl5 | Mouse | glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CCL5 mRNA | CTD | PMID:17178593 |
Ccl5 | Mouse | glucose | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Glucose results in increased expression of CCL5 mRNA | CTD | PMID:31655124 |
Ccl5 | Mouse | glucose | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Glucose results in decreased expression of CCL5 mRNA | CTD | PMID:32942007 |
Ccl5 | Mouse | glucose | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA | CTD | PMID:32613381 |
Ccl5 | Mouse | glutathione | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Glutathione inhibits the reaction [[Particulate Matter analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased secretion of CCL5 protein] more ... | CTD | PMID:10919993 |
Ccl5 | Mouse | glycine betaine | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Betaine results in increased expression of CCL5 mRNA | CTD | PMID:26391144 |
Ccl5 | Mouse | gold atom | multiple interactions | EXP | | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein | CTD | PMID:22155353 |
Ccl5 | Mouse | gold atom | increases secretion | EXP | | 6480464 | Gold results in increased secretion of CCL5 protein | CTD | PMID:22155353 |
Ccl5 | Mouse | gold(0) | multiple interactions | EXP | | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein | CTD | PMID:22155353 |
Ccl5 | Mouse | gold(0) | increases secretion | EXP | | 6480464 | Gold results in increased secretion of CCL5 protein | CTD | PMID:22155353 |
Ccl5 | Mouse | graphene oxide | increases expression | EXP | | 6480464 | graphene oxide analog results in increased expression of CCL5 mRNA | CTD | PMID:33227293 |
Ccl5 | Mouse | GW 1929 | decreases response to substance | ISO | CCL5 (Homo sapiens) | 6480464 | GW 1929 results in decreased susceptibility to CCL5 protein | CTD | PMID:18158351 |
Ccl5 | Mouse | helenalin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | helenalin inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] | CTD | PMID:23688403 |
Ccl5 | Mouse | heparan sulfate | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Heparitin Sulfate inhibits the reaction [Hydrogen Peroxide results in increased degradation of [CCL5 protein binds to CCL5 protein]] and Heparitin Sulfate inhibits the reaction [Hydrogen Peroxide results in increased degradation of CCL5 protein] | CTD | PMID:21963154 |
Ccl5 | Mouse | hesperetin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | hesperetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein] | CTD | PMID:24707119 |
Ccl5 | Mouse | hexadecanoic acid | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA | CTD | PMID:32613381 |
Ccl5 | Mouse | homocysteine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Homocysteine co-treated with Lipopolysaccharides] results in increased secretion of CCL5 protein | CTD | PMID:16225753 |
Ccl5 | Mouse | homocysteine | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Ibuprofen inhibits the reaction [Homocysteine results in increased expression of CCL5 protein] | CTD | PMID:39357784 |
Ccl5 | Mouse | homocysteine | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Homocysteine results in increased expression of CCL5 protein | CTD | PMID:39357784 |
Ccl5 | Mouse | homocysteine | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Homocysteine results in increased expression of CCL5 mRNA | CTD | PMID:16225753 |
Ccl5 | Mouse | hyaluronic acid | increases secretion | EXP | | 6480464 | Hyaluronic Acid analog results in increased secretion of CCL5 protein | CTD | PMID:9278343 |
Ccl5 | Mouse | hydrazines | increases expression | EXP | | 6480464 | Hydrazines results in increased expression of CCL5 mRNA | CTD | PMID:21647536 |
Ccl5 | Mouse | hydrogen peroxide | increases degradation | ISO | CCL5 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased degradation of CCL5 protein | CTD | PMID:21963154 |
Ccl5 | Mouse | hydrogen peroxide | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of CCL5 protein | CTD | PMID:18441283 |
Ccl5 | Mouse | hydrogen peroxide | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Copper co-treated with Hydrogen Peroxide] promotes the reaction [CCL5 protein binds to CCL5 protein] more ... | CTD | PMID:18441283 and PMID:21963154 |
Ccl5 | Mouse | hydroquinone | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | hydroquinone results in increased expression of CCL5 protein | CTD | PMID:17572062 |
Ccl5 | Mouse | hydroxytyrosol | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3 and 4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA | CTD | PMID:16797527 |
Ccl5 | Mouse | ibuprofen | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Ibuprofen inhibits the reaction [Homocysteine results in increased expression of CCL5 protein] | CTD | PMID:39357784 |
Ccl5 | Mouse | indometacin | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Indomethacin affects the expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | ionomycin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL5 protein more ... | CTD | PMID:17572062 and PMID:17685462 |
Ccl5 | Mouse | iron atom | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Iron deficiency results in increased expression of CCL5 mRNA | CTD | PMID:20368581 |
Ccl5 | Mouse | iron(0) | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Iron deficiency results in increased expression of CCL5 mRNA | CTD | PMID:20368581 |
Ccl5 | Mouse | isotretinoin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Isotretinoin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] and Isotretinoin inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] | CTD | PMID:15972972 |
Ccl5 | Mouse | isotretinoin | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Isotretinoin results in decreased expression of CCL5 mRNA | CTD | PMID:15972972 |
Ccl5 | Mouse | isotretinoin | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of CCL5 mRNA | CTD | PMID:15972972 |
Ccl5 | Mouse | itraconazole | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] | CTD | PMID:23688403 |
Ccl5 | Mouse | ivermectin | multiple interactions | EXP | | 6480464 | Ivermectin inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL5 mRNA] | CTD | PMID:36555680 |
Ccl5 | Mouse | Jujuboside A | multiple interactions | EXP | | 6480464 | jujuboside A affects the reaction [[Midazolam co-treated with Lipopolysaccharides] affects the expression of CCL5 mRNA] | CTD | PMID:37330271 |
Ccl5 | Mouse | kaempferol | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3 and 4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA | CTD | PMID:16797527 |
Ccl5 | Mouse | ketamine | multiple interactions | EXP | | 6480464 | [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 mRNA] and [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 protein] | CTD | PMID:22245128 |
Ccl5 | Mouse | ketoconazole | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]] more ... | CTD | PMID:16784723 and PMID:23688403 |
Ccl5 | Mouse | ketoconazole | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Ketoconazole results in increased expression of CCL5 mRNA | CTD | PMID:37077353 |
Ccl5 | Mouse | lanatoside C | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | lanatoside C results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | lanthanum trichloride | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [cerous chloride co-treated with lanthanum chloride] results in increased expression of CCL5 mRNA | CTD | PMID:28954213 |
Ccl5 | Mouse | lanthanum trichloride | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | lanthanum chloride results in increased expression of CCL5 mRNA | CTD | PMID:28954213 |
Ccl5 | Mouse | lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of CCL5 mRNA | CTD | PMID:29746905 |
Ccl5 | Mouse | lead(0) | multiple interactions | EXP | | 6480464 | Lead results in increased expression of and results in increased secretion of CCL5 protein | CTD | PMID:28973681 |
Ccl5 | Mouse | lead(II) chloride | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | lead chloride results in increased secretion of CCL5 protein | CTD | PMID:16099135 |
Ccl5 | Mouse | leukotriene B4 | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4 more ... | CTD | PMID:18083043 |
Ccl5 | Mouse | lipopolysaccharide | increases secretion | EXP | | 6480464 | Lipopolysaccharides results in increased secretion of CCL5 protein | CTD | PMID:24561310 and PMID:32800949 |
Ccl5 | Mouse | lipopolysaccharide | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Lipopolysaccharides results in increased expression of CCL5 mRNA and Lipopolysaccharides results in increased expression of CCL5 protein | CTD | PMID:28693884 and PMID:33727093 |
Ccl5 | Mouse | lipopolysaccharide | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Lipopolysaccharides inhibits the reaction [Rutin results in decreased expression of CCL5 mRNA] | CTD | PMID:28693884 |
Ccl5 | Mouse | lipopolysaccharide | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased secretion of CCL5 protein | CTD | PMID:15289356 more ... |
Ccl5 | Mouse | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of CCL5 mRNA and Lipopolysaccharides results in increased expression of CCL5 protein | CTD | PMID:19133137 more ... |
Ccl5 | Mouse | lipopolysaccharide | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:15460210 more ... |
Ccl5 | Mouse | lipopolysaccharide | multiple interactions | EXP | | 6480464 | (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] more ... | CTD | PMID:15135318 more ... |
Ccl5 | Mouse | lipopolysaccharide | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of CCL5 mRNA and Lipopolysaccharides results in increased expression of CCL5 protein | CTD | PMID:15460210 more ... |
Ccl5 | Mouse | losartan | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Losartan inhibits the reaction [Ethylene Glycol results in increased expression of CCL5 protein] | CTD | PMID:16284884 |
Ccl5 | Mouse | Luliconazole | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | luliconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] | CTD | PMID:23688403 |
Ccl5 | Mouse | LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] | CTD | PMID:22225513 |
Ccl5 | Mouse | lycopene | multiple interactions | EXP | | 6480464 | Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CCL5 mRNA] | CTD | PMID:36583613 |
Ccl5 | Mouse | manganese(II) chloride | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | manganese chloride results in increased expression of CCL5 mRNA | CTD | PMID:28801915 |
Ccl5 | Mouse | mangiferin | multiple interactions | EXP | | 6480464 | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein] | CTD | PMID:15135318 |
Ccl5 | Mouse | maraviroc | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | maraviroc inhibits the reaction [CCL5 protein binds to CCR5 protein] | CTD | PMID:15644495 |
Ccl5 | Mouse | masoprocol | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Masoprocol inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4] more ... | CTD | PMID:18083043 |
Ccl5 | Mouse | mechlorethamine | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Mechlorethamine results in increased expression of CCL5 mRNA | CTD | PMID:26273949 |
Ccl5 | Mouse | meclocycline | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | meclocycline results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] | CTD | PMID:22225513 |
Ccl5 | Mouse | melatonin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Melatonin inhibits the reaction [cyfluthrin results in increased expression of CCL5 mRNA] | CTD | PMID:31330490 |
Ccl5 | Mouse | menadione | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of CCL5 mRNA] and Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of CCL5 protein] | CTD | PMID:19265712 |
Ccl5 | Mouse | menadione | increases secretion | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Vitamin K 3 results in increased secretion of CCL5 protein | CTD | PMID:19265712 |
Ccl5 | Mouse | menadione | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Vitamin K 3 results in increased expression of CCL5 mRNA | CTD | PMID:19265712 |
Ccl5 | Mouse | mercaptopurine | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Mercaptopurine results in decreased expression of CCL5 mRNA | CTD | PMID:23358152 |
Ccl5 | Mouse | mercury dichloride | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Mercuric Chloride results in increased expression of CCL5 mRNA and Mercuric Chloride results in increased expression of CCL5 protein | CTD | PMID:12834626 |
Ccl5 | Mouse | mercury dichloride | increases response to substance | ISO | Ccl5 (Rattus norvegicus) | 6480464 | CCL5 protein results in increased susceptibility to Mercuric Chloride | CTD | PMID:12834626 |
Ccl5 | Mouse | metam | multiple interactions | EXP | | 6480464 | methyldithiocarbamate inhibits the reaction [Poly I-C results in increased secretion of CCL5 protein] | CTD | PMID:24056979 |
Ccl5 | Mouse | methamphetamine | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Methamphetamine results in decreased expression of CCL5 mRNA | CTD | PMID:19564919 |
Ccl5 | Mouse | methapyrilene | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Methapyrilene results in increased expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | methionine sulfoximine | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Methionine Sulfoximine results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | methotrexate | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | SB 203580 promotes the reaction [Methotrexate results in increased expression of CCL5 protein] | CTD | PMID:19100307 |
Ccl5 | Mouse | methotrexate | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of CCL5 mRNA | CTD | PMID:17400583 |
Ccl5 | Mouse | methotrexate | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of CCL5 mRNA and Methotrexate results in increased expression of CCL5 protein | CTD | PMID:19100307 and PMID:21678067 |
Ccl5 | Mouse | methoxychlor | affects methylation | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of CCL5 gene | CTD | PMID:35440735 |
Ccl5 | Mouse | Methylbenzethonium chloride | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | methylbenzethonium chloride results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | methylisothiazolinone | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased secretion of CCL5 protein | CTD | PMID:30806763 |
Ccl5 | Mouse | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of CCL5 mRNA | CTD | PMID:24213012 |
Ccl5 | Mouse | methylmercury chloride | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [Hydrocarbons more ... | CTD | PMID:30744511 |
Ccl5 | Mouse | methylmercury chloride | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | methylmercuric chloride results in increased expression of CCL5 protein | CTD | PMID:28526320 |
Ccl5 | Mouse | methylmercury chloride | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of CCL5 mRNA | CTD | PMID:29581082 |
Ccl5 | Mouse | microcystin-LR | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [Dietary Fats co-treated with Cholesterol and Dietary co-treated with cyanoginosin LR] results in increased expression of CCL5 protein | CTD | PMID:34740672 |
Ccl5 | Mouse | microcystin-LR | increases expression | EXP | | 6480464 | cyanoginosin LR results in increased expression of CCL5 mRNA | CTD | PMID:37342990 |
Ccl5 | Mouse | midazolam | multiple interactions | EXP | | 6480464 | [Midazolam co-treated with Lipopolysaccharides] affects the expression of CCL5 mRNA and jujuboside A affects the reaction [[Midazolam co-treated with Lipopolysaccharides] affects the expression of CCL5 mRNA] | CTD | PMID:37330271 |
Ccl5 | Mouse | minocycline | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Minocycline results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | minocycline | multiple interactions | EXP | | 6480464 | Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of CCL5 protein] | CTD | PMID:35351628 |
Ccl5 | Mouse | monocrotaline | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Monocrotaline affects the expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | monodansylcadaverine | multiple interactions | EXP | | 6480464 | monodansylcadaverine inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased secretion of CCL5 protein] | CTD | PMID:22341560 |
Ccl5 | Mouse | morphine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | beta-funaltrexamine inhibits the reaction [Morphine results in decreased expression of CCL5 protein] and Naloxone inhibits the reaction [Morphine results in decreased expression of CCL5 protein] | CTD | PMID:11106302 |
Ccl5 | Mouse | morphine | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Morphine results in decreased expression of CCL5 protein | CTD | PMID:11106302 |
Ccl5 | Mouse | mycophenolic acid | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [Quercetin co-treated with Mycophenolic Acid] results in decreased expression of CCL5 mRNA | CTD | PMID:10688038 |
Ccl5 | Mouse | mycophenolic acid | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Mycophenolic Acid results in decreased expression of CCL5 mRNA | CTD | PMID:10688038 |
Ccl5 | Mouse | N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | CTD | PMID:10495789 |
Ccl5 | Mouse | N-acetyl-L-cysteine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of CCL5 protein] more ... | CTD | PMID:11167962 more ... |
Ccl5 | Mouse | N-methyl-4-phenylpyridinium | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of CCL5 mRNA | CTD | PMID:28801915 |
Ccl5 | Mouse | N-methyl-N-nitrosourea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of CCL5 mRNA | CTD | PMID:15240709 |
Ccl5 | Mouse | N-nitrosodiethylamine | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Diethylnitrosamine results in decreased expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | N-nitrosodiethylamine | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CCL5 mRNA | CTD | PMID:20360939 |
Ccl5 | Mouse | N-nitrosodiethylamine | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Diethylnitrosamine results in increased expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | N-nitrosodimethylamine | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Dimethylnitrosamine results in increased expression of CCL5 mRNA | CTD | PMID:25380136 |
Ccl5 | Mouse | naloxone | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Naloxone inhibits the reaction [Morphine results in decreased expression of CCL5 protein] | CTD | PMID:11106302 |
Ccl5 | Mouse | naringin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | naringin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CCL5 protein] | CTD | PMID:21500970 |
Ccl5 | Mouse | neocuproine | multiple interactions | EXP | | 6480464 | neocuproine inhibits the reaction [lipopolysaccharide and E coli O55-B5 results in increased expression of CCL5 protein] | CTD | PMID:23604539 |
Ccl5 | Mouse | neoechinulin A | increases expression | EXP | | 6480464 | neoechinulin A results in increased expression of CCL5 mRNA | CTD | PMID:19818335 |
Ccl5 | Mouse | nickel atom | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA | CTD | PMID:23503329 |
Ccl5 | Mouse | nickel atom | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Nickel results in increased expression of CCL5 mRNA | CTD | PMID:24768652 and PMID:25583101 |
Ccl5 | Mouse | nickel dichloride | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | nickel chloride results in increased secretion of CCL5 protein | CTD | PMID:18437699 |
Ccl5 | Mouse | nickel sulfate | affects expression | ISO | CCL5 (Homo sapiens) | 6480464 | nickel sulfate affects the expression of CCL5 mRNA | CTD | PMID:18202158 |
Ccl5 | Mouse | nickel sulfate | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | nickel sulfate results in increased secretion of CCL5 protein | CTD | PMID:16099135 |
Ccl5 | Mouse | niclosamide | multiple interactions | EXP | | 6480464 | Niclosamide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL5 protein] | CTD | PMID:24561310 |
Ccl5 | Mouse | nicotine | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Nicotine results in increased expression of CCL5 mRNA | CTD | PMID:18247414 |
Ccl5 | Mouse | nitric oxide | decreases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | Nitric Oxide results in decreased secretion of CCL5 protein | CTD | PMID:13678430 |
Ccl5 | Mouse | nitric oxide | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide] more ... | CTD | PMID:19016906 |
Ccl5 | Mouse | nitrogen dioxide | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Nitrogen Dioxide results in increased expression of CCL5 mRNA | CTD | PMID:27206323 |
Ccl5 | Mouse | o-anisidine | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | 2-anisidine results in increased expression of CCL5 mRNA | CTD | PMID:28089782 |
Ccl5 | Mouse | ochratoxin A | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | ochratoxin A affects the expression of CCL5 mRNA | CTD | PMID:32468156 |
Ccl5 | Mouse | oxaliplatin | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of CCL5 mRNA | CTD | PMID:25729387 |
Ccl5 | Mouse | oxaliplatin | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | oxaliplatin results in increased expression of CCL5 mRNA | CTD | PMID:25729387 |
Ccl5 | Mouse | oxytetracycline | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Oxytetracycline results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of CCL5 mRNA | CTD | PMID:12763052 and PMID:33026818 |
Ccl5 | Mouse | ozone | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CCL5 protein and [Aripiprazole co-treated with Ozone] results in increased expression of CCL5 mRNA | CTD | PMID:24641287 and PMID:31476115 |
Ccl5 | Mouse | ozone | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Ozone results in increased expression of CCL5 mRNA | CTD | PMID:31476115 |
Ccl5 | Mouse | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CCL5 mRNA more ... | CTD | PMID:27472835 and PMID:34911549 |
Ccl5 | Mouse | palmatine | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | palmatine results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CCL5 mRNA | CTD | PMID:17562736 |
Ccl5 | Mouse | paracetamol | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CCL5 mRNA | CTD | PMID:29067470 |
Ccl5 | Mouse | paracetamol | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of CCL5 mRNA] and Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of CCL5 protein] | CTD | PMID:19265712 |
Ccl5 | Mouse | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CCL5 mRNA | CTD | PMID:15578514 |
Ccl5 | Mouse | paraquat | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Paraquat results in increased expression of CCL5 protein | CTD | PMID:36108500 |
Ccl5 | Mouse | parthenolide | multiple interactions | EXP | | 6480464 | parthenolide inhibits the reaction [Cyclosporine results in increased expression of CCL5 mRNA] and parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA] | CTD | PMID:23958496 |
Ccl5 | Mouse | PCB138 | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:23829299 |
Ccl5 | Mouse | PD123319 | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | PD 123319 inhibits the reaction [Ethylene Glycol results in increased expression of CCL5 protein] | CTD | PMID:16284884 |
Ccl5 | Mouse | pentachlorophenol | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | Pentachlorophenol results in increased secretion of CCL5 protein | CTD | PMID:35550411 |
Ccl5 | Mouse | pentanal | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | pentanal results in increased expression of CCL5 mRNA | CTD | PMID:26079696 |
Ccl5 | Mouse | Pentoxifylline | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Pentoxifylline results in decreased expression of CCL5 mRNA | CTD | PMID:14993492 |
Ccl5 | Mouse | perfluorohexanesulfonic acid | decreases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in decreased expression of CCL5 mRNA | CTD | PMID:37995155 |
Ccl5 | Mouse | perfluorooctane-1-sulfonic acid | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CCL5 mRNA | CTD | PMID:19162173 |
Ccl5 | Mouse | perfluorooctanoic acid | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of CCL5 mRNA | CTD | PMID:36326898 |
Ccl5 | Mouse | perfluorooctanoic acid | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of CCL5 mRNA | CTD | PMID:37738295 |
Ccl5 | Mouse | permethrin | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Permethrin results in increased expression of CCL5 protein | CTD | PMID:21616133 |
Ccl5 | Mouse | pevonedistat | affects expression | ISO | CCL5 (Homo sapiens) | 6480464 | pevonedistat affects the expression of CCL5 mRNA | CTD | PMID:24634471 |
Ccl5 | Mouse | phenethyl caffeate | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CCL5 mRNA | CTD | PMID:20360939 |
Ccl5 | Mouse | phenobarbital | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Phenobarbital affects the expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | phloretin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein] | CTD | PMID:24707119 |
Ccl5 | Mouse | phorbol 13-acetate 12-myristate | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL5 protein more ... | CTD | PMID:17572062 and PMID:17685462 |
Ccl5 | Mouse | phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of CCL5 mRNA | CTD | PMID:31904401 |
Ccl5 | Mouse | phytoestrogen | decreases expression | EXP | | 6480464 | Phytoestrogens results in decreased expression of CCL5 protein | CTD | PMID:24388399 |
Ccl5 | Mouse | pioglitazone | multiple interactions | EXP | | 6480464 | pioglitazone inhibits the reaction [Toluene 2 and 4-Diisocyanate results in increased expression of CCL5 protein] | CTD | PMID:17015710 |
Ccl5 | Mouse | pioglitazone | decreases response to substance | ISO | CCL5 (Homo sapiens) | 6480464 | pioglitazone results in decreased susceptibility to CCL5 protein | CTD | PMID:18158351 |
Ccl5 | Mouse | pirinixic acid | multiple interactions | EXP | | 6480464 | pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL5 mRNA] and pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL5 protein] | CTD | PMID:15814532 |
Ccl5 | Mouse | pirinixic acid | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | pirinixic acid results in decreased expression of CCL5 mRNA | CTD | PMID:12832660 |
Ccl5 | Mouse | pirinixic acid | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | pirinixic acid results in increased expression of CCL5 mRNA | CTD | PMID:19162173 |
Ccl5 | Mouse | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CCL5 mRNA | CTD | PMID:17426115 |
Ccl5 | Mouse | platycodin D | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | platycodin D inhibits the reaction [IL1B protein results in increased secretion of CCL5 protein] | CTD | PMID:27743553 |
Ccl5 | Mouse | poly(I:C) | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | 15-deoxy-delta(12 more ... | CTD | PMID:23688403 more ... |
Ccl5 | Mouse | poly(I:C) | increases expression | EXP | | 6480464 | Poly I-C results in increased expression of CCL5 mRNA | CTD | PMID:25780039 |
Ccl5 | Mouse | poly(I:C) | increases secretion | EXP | | 6480464 | Poly I-C results in increased secretion of CCL5 protein | CTD | PMID:24056979 |
Ccl5 | Mouse | poly(I:C) | multiple interactions | EXP | | 6480464 | APPL1 protein promotes the reaction [Poly I-C results in increased expression of CCL5 mRNA] more ... | CTD | PMID:24056979 and PMID:25780039 |
Ccl5 | Mouse | poly(I:C) | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Poly I-C results in increased expression of CCL5 and Poly I-C results in increased expression of CCL5 mRNA | CTD | PMID:23688403 and PMID:24709138 |
Ccl5 | Mouse | polymyxin B2 | multiple interactions | EXP | | 6480464 | Polymyxin B inhibits the reaction [[Ovalbumin co-treated with Dust] results in increased expression of CCL5 protein] | CTD | PMID:26882889 |
Ccl5 | Mouse | polymyxin B2 | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Polymyxin B inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased secretion of CCL5 protein] | CTD | PMID:29348435 |
Ccl5 | Mouse | prazosin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Prazosin inhibits the reaction [Norepinephrine results in increased secretion of CCL5 protein] | CTD | PMID:16782692 |
Ccl5 | Mouse | procyanidin B3 | multiple interactions | EXP | | 6480464 | [procyanidin B3 co-treated with Eicosapentaenoic Acid] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] | CTD | PMID:22169119 |
Ccl5 | Mouse | progesterone | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of CCL5 mRNA and TGFB1 protein promotes the reaction [Progesterone results in increased expression of CCL5 mRNA] | CTD | PMID:17404688 and PMID:21768398 |
Ccl5 | Mouse | progesterone | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of CCL5 mRNA and [Estradiol co-treated with Progesterone] results in decreased expression of CCL5 protein | CTD | PMID:21277368 |
Ccl5 | Mouse | progesterone | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Progesterone results in increased expression of CCL5 mRNA | CTD | PMID:21768398 |
Ccl5 | Mouse | propanal | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of CCL5 mRNA | CTD | PMID:26079696 |
Ccl5 | Mouse | propidium | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Propidium results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | Proscillaridin | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Proscillaridin results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
Ccl5 | Mouse | prostaglandin E2 | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Dinoprostone results in decreased expression of CCL5 mRNA | CTD | PMID:16303787 |
Ccl5 | Mouse | prostaglandin E2 | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]] more ... | CTD | PMID:16784723 |
Ccl5 | Mouse | prostaglandin E2 | multiple interactions | EXP | | 6480464 | Dinoprostone inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] more ... | CTD | PMID:10495789 and PMID:17667525 |
Ccl5 | Mouse | purine-6-thiol | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Mercaptopurine results in decreased expression of CCL5 mRNA | CTD | PMID:23358152 |
Ccl5 | Mouse | pyocyanine | decreases expression | EXP | | 6480464 | Pyocyanine results in decreased expression of CCL5 mRNA and Pyocyanine results in decreased expression of CCL5 protein | CTD | PMID:31078726 |
Ccl5 | Mouse | pyrrolidine dithiocarbamate | multiple interactions | EXP | | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] and pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | CTD | PMID:10495789 and PMID:22225513 |
Ccl5 | Mouse | quartz | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Quartz results in increased expression of CCL5 mRNA | CTD | PMID:27917503 |
Ccl5 | Mouse | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of CCL5 mRNA | CTD | PMID:16455785 |
Ccl5 | Mouse | quercetin | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Quercetin results in decreased expression of CCL5 mRNA | CTD | PMID:10688038 |
Ccl5 | Mouse | quercetin | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3 and 4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA | CTD | PMID:16797527 |
Ccl5 | Mouse | quercetin | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [Quercetin co-treated with Mycophenolic Acid] results in decreased expression of CCL5 mRNA and Quercetin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] | CTD | PMID:10688038 and PMID:14654164 |
Ccl5 | Mouse | quercetin 3-O-beta-D-glucofuranoside | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] | CTD | PMID:14654164 |
Ccl5 | Mouse | quercetin 3-O-beta-D-glucopyranoside | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] | CTD | PMID:14654164 |
Ccl5 | Mouse | raloxifene | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Raloxifene Hydrochloride results in increased expression of CCL5 mRNA | CTD | PMID:12154049 |
Ccl5 | Mouse | raloxifene | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Raloxifene Hydrochloride results in decreased expression of CCL5 protein | CTD | PMID:16842799 |
Ccl5 | Mouse | reactive oxygen species | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species] and IL5 protein promotes the reaction [CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]] | CTD | PMID:12797483 |
Ccl5 | Mouse | reactive oxygen species | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:10495789 and PMID:19016906 |
Ccl5 | Mouse | reactive oxygen species | increases expression | EXP | | 6480464 | Reactive Oxygen Species results in increased expression of CCL5 mRNA | CTD | PMID:10495789 |
Ccl5 | Mouse | resveratrol | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CCL5 protein] and resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein] | CTD | PMID:24707119 and PMID:24895526 |
Ccl5 | Mouse | resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [lipopolysaccharide more ... | CTD | PMID:24041027 |
Ccl5 | Mouse | resveratrol | decreases expression | EXP | | 6480464 | resveratrol analog results in decreased expression of CCL5 mRNA and resveratrol results in decreased expression of CCL5 protein | CTD | PMID:15652768 more ... |
Ccl5 | Mouse | rifampicin | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Rifampin results in decreased expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | rofecoxib | increases expression | EXP | | 6480464 | rofecoxib results in increased expression of CCL5 mRNA and rofecoxib results in increased expression of CCL5 protein | CTD | PMID:17667525 |
Ccl5 | Mouse | rofecoxib | multiple interactions | EXP | | 6480464 | Dinoprostone inhibits the reaction [rofecoxib results in increased expression of CCL5 mRNA] and Dinoprostone inhibits the reaction [rofecoxib results in increased expression of CCL5 protein] | CTD | PMID:17667525 |
Ccl5 | Mouse | rutin | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Lipopolysaccharides inhibits the reaction [Rutin results in decreased expression of CCL5 mRNA] | CTD | PMID:28693884 |
Ccl5 | Mouse | rutin | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Rutin results in decreased expression of CCL5 mRNA | CTD | PMID:28693884 |
Ccl5 | Mouse | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 |
Ccl5 | Mouse | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Buthionine Sulfoximine promotes the reaction [TNF protein results in increased expression of CCL5 protein] and SB 203580 inhibits the reaction [Buthionine Sulfoximine promotes the reaction [TNF protein results in increased expression of CCL5 protein]] | CTD | PMID:11167962 |
Ccl5 | Mouse | S-nitrosoglutathione | decreases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | S-Nitrosoglutathione results in decreased secretion of CCL5 protein | CTD | PMID:13678430 |
Ccl5 | Mouse | salubrinal | multiple interactions | EXP | | 6480464 | salubrinal inhibits the reaction [Cyclosporine results in increased expression of CCL5 mRNA] and salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA] | CTD | PMID:23958496 |
Ccl5 | Mouse | SB 203580 | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | SB 203580 inhibits the reaction [[Toluene 2 more ... | CTD | PMID:10919993 more ... |
Ccl5 | Mouse | serotonin | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Serotonin results in increased expression of CCL5 protein | CTD | PMID:38701902 |
Ccl5 | Mouse | serpentine asbestos | increases expression | EXP | | 6480464 | Asbestos and Serpentine results in increased expression of CCL5 protein | CTD | PMID:17200189 |
Ccl5 | Mouse | serpentine asbestos | multiple interactions | EXP | | 6480464 | PRKDC affects the reaction [Asbestos and Serpentine results in increased expression of CCL5 protein] | CTD | PMID:17200189 |
Ccl5 | Mouse | silicon dioxide | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of CCL5 mRNA and Silicon Dioxide results in increased expression of CCL5 mRNA | CTD | PMID:23806026 more ... |
Ccl5 | Mouse | silicon dioxide | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | Silicon Dioxide results in increased secretion of CCL5 protein | CTD | PMID:22300531 |
Ccl5 | Mouse | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of CCL5 mRNA | CTD | PMID:23221170 and PMID:29341224 |
Ccl5 | Mouse | silicon dioxide | multiple interactions | EXP | | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein | CTD | PMID:22155353 |
Ccl5 | Mouse | silicon dioxide | increases secretion | EXP | | 6480464 | Silicon Dioxide results in increased secretion of CCL5 protein | CTD | PMID:19073995 |
Ccl5 | Mouse | silver atom | affects expression | EXP | | 6480464 | Silver affects the expression of CCL5 mRNA | CTD | PMID:27131904 |
Ccl5 | Mouse | silver(0) | affects expression | EXP | | 6480464 | Silver affects the expression of CCL5 mRNA | CTD | PMID:27131904 |
Ccl5 | Mouse | simvastatin | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Simvastatin results in increased expression of CCL5 mRNA | CTD | PMID:17183729 |
Ccl5 | Mouse | simvastatin | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Simvastatin results in decreased expression of CCL5 protein | CTD | PMID:17449418 |
Ccl5 | Mouse | simvastatin | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Simvastatin results in decreased expression of CCL5 mRNA | CTD | PMID:17112859 |
Ccl5 | Mouse | sodium arsenite | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of CCL5 mRNA | CTD | PMID:28229933 and PMID:38568856 |
Ccl5 | Mouse | sodium arsenite | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of CCL5 protein and Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of CCL5 protein] | CTD | PMID:35351628 and PMID:35777461 |
Ccl5 | Mouse | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of CCL5 mRNA | CTD | PMID:37682722 |
Ccl5 | Mouse | sodium chloride | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Sodium Chloride results in increased expression of CCL5 protein | CTD | PMID:20232302 |
Ccl5 | Mouse | sodium cholate | multiple interactions | EXP | | 6480464 | [eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of CCL5 mRNA | CTD | PMID:23665937 |
Ccl5 | Mouse | sodium dichromate | decreases expression | EXP | | 6480464 | sodium bichromate results in decreased expression of CCL5 mRNA | CTD | PMID:22155349 |
Ccl5 | Mouse | sodium dichromate | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | sodium bichromate results in increased secretion of CCL5 protein | CTD | PMID:17685462 |
Ccl5 | Mouse | sodium dichromate | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL5 protein] | CTD | PMID:17685462 |
Ccl5 | Mouse | sodium dodecyl sulfate | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in increased secretion of CCL5 protein | CTD | PMID:16099135 |
Ccl5 | Mouse | sodium dodecyl sulfate | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in increased expression of CCL5 mRNA | CTD | PMID:31734321 |
Ccl5 | Mouse | Sodium oleate | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA | CTD | PMID:32613381 |
Ccl5 | Mouse | Soman | multiple interactions | EXP | | 6480464 | [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 mRNA] and [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 protein] | CTD | PMID:22245128 |
Ccl5 | Mouse | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of CCL5 mRNA and Soman results in increased expression of CCL5 protein | CTD | PMID:22245128 |
Ccl5 | Mouse | streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of CCL5 mRNA | CTD | PMID:29420703 |
Ccl5 | Mouse | succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL5 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL5 mRNA | CTD | PMID:21641980 and PMID:26378955 |
Ccl5 | Mouse | succimer | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL5 mRNA | CTD | PMID:26378955 |
Ccl5 | Mouse | sulforaphane | multiple interactions | EXP | | 6480464 | sulforaphane inhibits the reaction [Cyclosporine results in increased expression of CCL5 mRNA] and sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA] | CTD | PMID:23958496 |
Ccl5 | Mouse | sulindac | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Sulindac inhibits the reaction [IL1B protein results in increased expression of CCL5 mRNA] and Sulindac inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | CTD | PMID:16159934 |
Ccl5 | Mouse | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of CCL5 mRNA | CTD | PMID:27560553 |
Ccl5 | Mouse | tacrine | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Tacrine results in decreased expression of CCL5 mRNA | CTD | PMID:12832660 |
Ccl5 | Mouse | tacrolimus hydrate | decreases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Tacrolimus results in decreased expression of CCL5 mRNA | CTD | PMID:15948978 |
Ccl5 | Mouse | tacrolimus hydrate | multiple interactions | EXP | | 6480464 | 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA] more ... | CTD | PMID:23958496 |
Ccl5 | Mouse | tacrolimus hydrate | increases expression | EXP | | 6480464 | Tacrolimus results in increased expression of CCL5 mRNA | CTD | PMID:23958496 and PMID:25270620 |
Ccl5 | Mouse | tamibarotene | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | tamibarotene results in increased expression of CCL5 mRNA | CTD | PMID:15498508 |
Ccl5 | Mouse | tamibarotene | decreases expression | EXP | | 6480464 | tamibarotene results in decreased expression of CCL5 mRNA | CTD | PMID:20861477 |
Ccl5 | Mouse | taurocholic acid | increases expression | EXP | | 6480464 | Taurocholic Acid results in increased expression of CCL5 mRNA | CTD | PMID:21224055 |
Ccl5 | Mouse | telmisartan | decreases response to substance | ISO | CCL5 (Homo sapiens) | 6480464 | telmisartan results in decreased susceptibility to CCL5 protein | CTD | PMID:18158351 |
Ccl5 | Mouse | temozolomide | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of CCL5 mRNA | CTD | PMID:31758290 |
Ccl5 | Mouse | terameprocol | multiple interactions | EXP | | 6480464 | terameprocol inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to CCL5 promoter]] | CTD | PMID:21138578 |
Ccl5 | Mouse | terbinafine | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Dinoprostone deficiency inhibits the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]] more ... | CTD | PMID:16784723 and PMID:23688403 |
Ccl5 | Mouse | tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of CCL5 mRNA | CTD | PMID:14729362 and PMID:15003993 |
Ccl5 | Mouse | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of CCL5 mRNA | CTD | PMID:15788153 |
Ccl5 | Mouse | testosterone | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCL5 mRNA | CTD | PMID:32741896 |
Ccl5 | Mouse | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CCL5 mRNA and Carbon Tetrachloride results in increased expression of CCL5 protein | CTD | PMID:17412915 more ... |
Ccl5 | Mouse | tetrachloromethane | multiple interactions | EXP | | 6480464 | Ivermectin inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL5 mRNA] | CTD | PMID:36555680 |
Ccl5 | Mouse | tetrachloromethane | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride affects the expression of CCL5 mRNA | CTD | PMID:15963342 |
Ccl5 | Mouse | tetrachloromethane | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of CCL5 mRNA | CTD | PMID:16239168 and PMID:31150632 |
Ccl5 | Mouse | Tetramethylthiourea | decreases expression | EXP | | 6480464 | tetramethylthiourea results in decreased expression of CCL5 mRNA | CTD | PMID:11128050 |
Ccl5 | Mouse | Tetramethylthiourea | multiple interactions | EXP | | 6480464 | tetramethylthiourea inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] and tetramethylthiourea inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | CTD | PMID:10495789 |
Ccl5 | Mouse | tetraphene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL5 mRNA | CTD | PMID:27858113 |
Ccl5 | Mouse | thioacetamide | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Thioacetamide affects the expression of CCL5 protein | CTD | PMID:25051504 |
Ccl5 | Mouse | thioacetamide | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of CCL5 mRNA | CTD | PMID:23411599 |
Ccl5 | Mouse | titanium dioxide | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | titanium dioxide results in increased expression of CCL5 mRNA | CTD | PMID:19695317 |
Ccl5 | Mouse | titanium dioxide | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of CCL5 protein | CTD | PMID:30711708 |
Ccl5 | Mouse | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of CCL5 mRNA | CTD | PMID:27760801 |
Ccl5 | Mouse | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of CCL5 mRNA and titanium dioxide results in increased expression of CCL5 protein | CTD | PMID:23557971 and PMID:28646487 |
Ccl5 | Mouse | titanium dioxide | increases secretion | ISO | CCL5 (Homo sapiens) | 6480464 | titanium dioxide results in increased secretion of CCL5 protein | CTD | PMID:20005940 |
Ccl5 | Mouse | tofacitinib | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Cycloheximide inhibits the reaction [tofacitinib inhibits the reaction [TNF protein results in increased expression of CCL5 protein]] more ... | CTD | PMID:22121136 |
Ccl5 | Mouse | toluene 2,4-diisocyanate | affects response to substance | ISO | CCL5 (Homo sapiens) | 6480464 | CCL5 gene polymorphism affects the susceptibility to Toluene 2 and 4-Diisocyanate | CTD | PMID:18447907 |
Ccl5 | Mouse | toluene 2,4-diisocyanate | decreases expression | EXP | | 6480464 | Toluene 2 and 4-Diisocyanate results in decreased expression of CCL5 mRNA | CTD | PMID:21404309 |
Ccl5 | Mouse | toluene 2,4-diisocyanate | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Toluene 2 and 4-Diisocyanate results in increased expression of CCL5 mRNA | CTD | PMID:15823807 |
Ccl5 | Mouse | toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2 more ... | CTD | PMID:11467998 more ... |
Ccl5 | Mouse | toluene 2,4-diisocyanate | multiple interactions | EXP | | 6480464 | BAY 11-7085 inhibits the reaction [Toluene 2 more ... | CTD | PMID:12356572 more ... |
Ccl5 | Mouse | toluene 2,4-diisocyanate | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Toluene 2 more ... | CTD | PMID:16908450 |
Ccl5 | Mouse | topotecan | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of CCL5 mRNA | CTD | PMID:25729387 |
Ccl5 | Mouse | topotecan | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Topotecan results in increased expression of CCL5 mRNA | CTD | PMID:25729387 |
Ccl5 | Mouse | trametinib | multiple interactions | EXP | | 6480464 | trametinib promotes the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] and trametinib promotes the reaction [Poly I-C results in increased expression of CCL5 mRNA] | CTD | PMID:25780039 |
Ccl5 | Mouse | tremolite asbestos | decreases expression | EXP | | 6480464 | tremolite results in decreased expression of CCL5 mRNA | CTD | PMID:29279043 |
Ccl5 | Mouse | triadimefon | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | triadimefon results in increased expression of CCL5 mRNA and triadimefon results in increased expression of CCL5 protein | CTD | PMID:36179991 |
Ccl5 | Mouse | triamcinolone acetonide | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Triamcinolone Acetonide inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] | CTD | PMID:10903220 |
Ccl5 | Mouse | tributylstannane | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [tributyltin co-treated with LHB protein] results in decreased secretion of CCL5 protein | CTD | PMID:38630605 |
Ccl5 | Mouse | Tributyltin oxide | decreases expression | EXP | | 6480464 | bis(tri-n-butyltin)oxide results in decreased expression of CCL5 mRNA | CTD | PMID:18958704 |
Ccl5 | Mouse | trichloroethene | decreases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of CCL5 mRNA | CTD | PMID:20955722 |
Ccl5 | Mouse | trichloroethene | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of CCL5 mRNA | CTD | PMID:33387578 |
Ccl5 | Mouse | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of CCL5 mRNA and Trichloroethylene results in increased expression of CCL5 protein | CTD | PMID:29669109 and PMID:33930529 |
Ccl5 | Mouse | triphenyl phosphate | affects expression | ISO | CCL5 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of CCL5 mRNA | CTD | PMID:37042841 |
Ccl5 | Mouse | troglitazone | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | troglitazone results in increased expression of CCL5 mRNA | CTD | PMID:19140230 |
Ccl5 | Mouse | tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate | multiple interactions | EXP | | 6480464 | [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 mRNA] and [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 protein] | CTD | PMID:22245128 |
Ccl5 | Mouse | urethane | multiple interactions | EXP | | 6480464 | [Urethane co-treated with Freund's Adjuvant] results in increased expression of CCL5 mRNA | CTD | PMID:12400877 |
Ccl5 | Mouse | ursodeoxycholic acid | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | Ursodeoxycholic Acid analog inhibits the reaction [TNF protein promotes the reaction [Cycloheximide results in increased expression of CCL5 mRNA]] | CTD | PMID:21146893 |
Ccl5 | Mouse | ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CCL5 mRNA] and Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased secretion of CCL5 protein] | CTD | PMID:21146893 |
Ccl5 | Mouse | vanadyl sulfate | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | vanadyl sulfate results in increased expression of CCL5 protein | CTD | PMID:18684396 |
Ccl5 | Mouse | verteporfin | multiple interactions | EXP | | 6480464 | Verteporfin inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased expression of CCL5 protein] | CTD | PMID:31812773 |
Ccl5 | Mouse | vinclozolin | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of CCL5 mRNA | CTD | PMID:19015723 |
Ccl5 | Mouse | vinclozolin | increases expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of CCL5 mRNA | CTD | PMID:23034163 |
Ccl5 | Mouse | vincristine | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | Vincristine results in increased expression of CCL5 mRNA | CTD | PMID:23649840 |
Ccl5 | Mouse | vitamin E | multiple interactions | ISO | CCL5 (Homo sapiens) | 6480464 | [Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3 and 4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA | CTD | PMID:16797527 |
Ccl5 | Mouse | wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide] and wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] | CTD | PMID:19016906 and PMID:22225513 |
Ccl5 | Mouse | WR-1065 | increases expression | ISO | CCL5 (Homo sapiens) | 6480464 | N-(2-mercaptoethyl)-1 and 3-diaminopropane results in increased expression of CCL5 mRNA | CTD | PMID:12007958 |
Ccl5 | Mouse | zinc atom | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA | CTD | PMID:23503329 |
Ccl5 | Mouse | zinc oxide | affects expression | ISO | Ccl5 (Rattus norvegicus) | 6480464 | Zinc Oxide affects the expression of CCL5 protein | CTD | PMID:33205376 |
Ccl5 | Mouse | zinc(0) | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA | CTD | PMID:23503329 |